Astrazeneca Plc Stock Target Price

AZNCF Stock  USD 151.21  3.20  2.16%   
AstraZeneca PLC fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Pink Sheet. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AstraZeneca Target Price Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AstraZeneca PLC's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics of similar companies.
100%
AstraZeneca PLC is currently under evaluation in target price category among its peers.

AstraZeneca Fundamentals

About AstraZeneca PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in AstraZeneca Pink Sheet

AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.


 

Trending Assets

ALPMF
Astellas Pharma
9.70  0.20  2.11 
RHHBF
Roche Holding AG
360.00  8.93  2.54 
RHHVF
Roche Holding AG
335.35  0.35  0.10 
DSKYF
Daiichi Sankyo
21.45  -1.45  -6.33 
BAYRY
Bayer AG PK
0.00  0.00  0.00 
RHHBY
Roche Holding
41.81  0.30  0.72 
ALPMY
Astellas Pharma
9.93  0.20  2.06 
BAYZF
Bayer AG
23.96  0.63  2.70 
BMYMP
Bristol Myers Squibb
900.55  0.00  0.00 
SNY
Sanofi ADR
54.89  1.14  2.12 
GRFS
Grifols SA ADR
7.38  -0.05  -0.67 
NVSEF
Novartis AG
111.16  5.16  4.87 
News Freq…Investor S…